The new drugs could become the way forward for medicated weight loss as clinical trials reveal optimistic results ...

With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits.

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the improvement of other conditions in longer studies.

Looking for ways to slim down and improve your health? You've probably heard about GLP-1s — the buzzworthy prescription medication behind some of today's most talked-about weight loss stories. They've ...

GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity or overweight with a related health condition. Read on for everything you need to know about GLP-1s for weight loss, ...

In early 2025, around 4.9 million British adults — almost one in ten — are estimated to have recently used, or expressed interest in using, glucagon-like peptide-1 (GLP-1) or dual ...

The World Health Organization (WHO) has announced its official guidance on the use of GLP-1 drugs for treating obesity. GLP-1 drugs are medications that mimic the natural hormone glucagon-like peptide ...

WHO guidelines conditionally endorse long-term GLP-1 therapy for obesity, emphasizing lifestyle modifications and addressing affordability and access challenges. GLP-1 therapies are included in the ...

Meanwhile, in attempts to address long-standing thyroid cancer concerns, a research team conducted a 350,000-person analysis ...

GLP-1 weight loss drugs have taken the food industry by storm. The drugs, which reduce “food noise”, the desire to eat, and increase feelings of fullness, are seen by some as an existential risk to ...